240 related articles for article (PubMed ID: 1396592)
1. The SCL gene product: a positive regulator of erythroid differentiation.
Aplan PD; Nakahara K; Orkin SH; Kirsch IR
EMBO J; 1992 Nov; 11(11):4073-81. PubMed ID: 1396592
[TBL] [Abstract][Full Text] [Related]
2. Lineage-restricted regulation of the murine SCL/TAL-1 promoter.
Bockamp EO; McLaughlin F; Murrell AM; Göttgens B; Robb L; Begley CG; Green AR
Blood; 1995 Aug; 86(4):1502-14. PubMed ID: 7632958
[TBL] [Abstract][Full Text] [Related]
3. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
[TBL] [Abstract][Full Text] [Related]
4. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
5. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation.
Hoang T; Paradis E; Brady G; Billia F; Nakahara K; Iscove NN; Kirsch IR
Blood; 1996 Jan; 87(1):102-11. PubMed ID: 8547631
[TBL] [Abstract][Full Text] [Related]
6. Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells.
Karacay B; Chang LS
Genomics; 1999 Jul; 59(1):6-17. PubMed ID: 10395794
[TBL] [Abstract][Full Text] [Related]
7. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
[TBL] [Abstract][Full Text] [Related]
8. Distinct mechanisms direct SCL/tal-1 expression in erythroid cells and CD34 positive primitive myeloid cells.
Bockamp EO; McLaughlin F; Göttgens B; Murrell AM; Elefanty AG; Green AR
J Biol Chem; 1997 Mar; 272(13):8781-90. PubMed ID: 9079714
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
10. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain.
Green AR; Lints T; Visvader J; Harvey R; Begley CG
Oncogene; 1992 Apr; 7(4):653-60. PubMed ID: 1565464
[TBL] [Abstract][Full Text] [Related]
11. SCL assembles a multifactorial complex that determines glycophorin A expression.
Lahlil R; Lécuyer E; Herblot S; Hoang T
Mol Cell Biol; 2004 Feb; 24(4):1439-52. PubMed ID: 14749362
[TBL] [Abstract][Full Text] [Related]
12. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
[TBL] [Abstract][Full Text] [Related]
13. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
14. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
Huang S; Qiu Y; Stein RW; Brandt SJ
Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
[TBL] [Abstract][Full Text] [Related]
15. Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1.
Lam LT; Ronchini C; Norton J; Capobianco AJ; Bresnick EH
J Biol Chem; 2000 Jun; 275(26):19676-84. PubMed ID: 10783395
[TBL] [Abstract][Full Text] [Related]
16. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene.
Vyas P; McDevitt MA; Cantor AB; Katz SG; Fujiwara Y; Orkin SH
Development; 1999 Jun; 126(12):2799-811. PubMed ID: 10331989
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of the erythroid transcription factor GATA-1.
Crossley M; Orkin SH
J Biol Chem; 1994 Jun; 269(24):16589-96. PubMed ID: 8206977
[TBL] [Abstract][Full Text] [Related]
18. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
Voronova AF; Lee F
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
Murrell AM; Green AR
Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
[TBL] [Abstract][Full Text] [Related]
20. Chromatin immunoselection defines a TAL-1 target gene.
Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
